GERN - Geron Corporation
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $-0.03
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$5.89
DETAILS
HIGH:
$8.00
LOW:
$4.00
MEDIAN:
$6.00
CONSENSUS:
$5.89
UPSIDE:
202.05%
Market Cap:
1.24B
Volume:
23,831,465
Avg Volume:
10,712,088
52 Week Range:
1.04-2.58
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.62
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
229
IPO Date:
1996-07-31
EPS (TTM):
-0.27
P/E Ratio:
-13.10
Revenue (TTM):
76.99M
Total Assets:
593.78M
Total Debt:
121.72M
Cash & Equiv:
79.02M
Rev Growth (5Y):
178.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-30.9%
Debt/Equity:
0.43
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $-0.03 | $-0.04 | +18.2% | $47.2M | $53.3M | -11.5% |
| 2025-08-06 | $-0.02 | $-0.03 | +33.3% | $49.0M | $47.3M | +3.7% |
| 2025-05-07 | $-0.03 | $-0.04 | +25.0% | $39.6M | $51.8M | -23.6% |
| 2025-02-26 | $-0.04 | $-0.04 | 0.0% | $47.5M | $45.3M | +5.0% |
| 2024-11-07 | $-0.04 | $-0.09 | +55.6% | $28.3M | $62.2M | -54.5% |
| 2024-08-08 | $-0.10 | $-0.11 | +9.1% | $882000 | $270000 | +226.7% |
| 2024-05-02 | $-0.09 | $-0.10 | +10.0% | $304000 | $270000 | +12.6% |
| 2024-02-28 | $-0.09 | $-0.10 | +10.0% | $23000 | $70000 | -67.1% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 76.99M | 237,000 | 596,000 | 1.39M | 253,000 | 460,000 | 1.07M | 1.06M | 6.16M | 36.37M | 1.15M | 1.28M |
| Net Income | (174.57M) | (184.13M) | (141.90M) | (116.11M) | (75.62M) | (68.55M) | (27.02M) | (27.92M) | (29.54M) | 46,000 | (35.67M) | (38.38M) |
| EPS | -0.27 | -0.32 | -0.37 | -0.37 | -0.28 | -0.33 | -0.15 | -0.18 | -0.19 | 0.00 | -0.23 | -0.30 |
| Total Assets | 593.78M | 394.08M | 190.57M | 226.03M | 270.73M | 165.52M | 185.28M | 110.31M | 130.25M | 148.76M | 172.51M | 67.34M |
| Total Debt | 121.72M | 85.90M | 55.75M | 55.00M | 29.72M | 2.55M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 79.02M | 70.02M | 56.84M | 34.87M | 9.93M | 13.64M | 10.84M | 16.60M | 13.08M | 21.52M | 43.06M | 12.99M |
| Operating Cash Flow | (218.62M) | (167.74M) | (127.38M) | (95.56M) | (66.65M) | (43.83M) | (21.01M) | (20.56M) | (18.37M) | (24.20M) | 9.35M | (36.68M) |
| Free Cash Flow | (219.30M) | (168.57M) | (127.81M) | (95.76M) | (67.05M) | (44.24M) | (21.02M) | (20.56M) | (18.43M) | (24.29M) | 9.22M | (36.68M) |
| FCF per Share | -0.34 | -0.30 | -0.34 | -0.29 | -0.25 | -0.23 | -0.12 | -0.13 | -0.12 | -0.15 | 0.06 | -0.29 |
| Book Value | 280.32M | 247.95M | 80.00M | 126.42M | 210.95M | 135.16M | 177.73M | 103.80M | 122.38M | 142.13M | 130.71M | 59.76M |
| Cash & ST Investments | 406.57M | 333.70M | 172.75M | 183.72M | 196.28M | 139.32M | 163.56M | 94.95M | 115.11M | 114.04M | 151.71M | 65.22M |
| ROC Equity | -0.62 | -0.74 | -1.77 | -0.92 | -0.36 | -0.51 | -0.15 | -0.27 | -0.24 | 0.00 | -0.27 | -0.64 |